SFE Investment Counsel lowered its position in HCP, Inc. (NYSE:HCP) by 1.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 228,906 shares of the real estate investment trust’s stock after selling 2,347 shares during the period. HCP comprises 3.0% of SFE Investment Counsel’s portfolio, making the stock its 3rd largest position. SFE Investment Counsel’s holdings in HCP were worth $7,316,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in HCP. Toronto Dominion Bank raised its stake in shares of HCP by 56.7% in the first quarter. Toronto Dominion Bank now owns 126,366 shares of the real estate investment trust’s stock worth $3,952,000 after buying an additional 45,734 shares during the period. Ameriprise Financial Inc. raised its position in HCP by 24.9% in the first quarter. Ameriprise Financial Inc. now owns 742,597 shares of the real estate investment trust’s stock valued at $23,230,000 after buying an additional 147,812 shares during the last quarter. Schwab Charles Investment Management Inc. raised its position in HCP by 3.0% in the first quarter. Schwab Charles Investment Management Inc. now owns 3,697,204 shares of the real estate investment trust’s stock valued at $115,649,000 after buying an additional 108,805 shares during the last quarter. Dubuque Bank & Trust Co. raised its position in HCP by 64.3% in the first quarter. Dubuque Bank & Trust Co. now owns 14,533 shares of the real estate investment trust’s stock valued at $455,000 after buying an additional 5,685 shares during the last quarter. Finally, IFP Advisors Inc raised its position in HCP by 9.5% in the first quarter. IFP Advisors Inc now owns 62,990 shares of the real estate investment trust’s stock valued at $1,970,000 after buying an additional 5,479 shares during the last quarter. 88.87% of the stock is currently owned by institutional investors.

HCP, Inc. (HCP) opened at 29.80 on Tuesday. The firm has a market capitalization of $13.98 billion, a price-to-earnings ratio of 20.31 and a beta of 0.37. HCP, Inc. has a 12 month low of $27.61 and a 12 month high of $40.43. The firm has a 50-day moving average price of $31.23 and a 200 day moving average price of $31.27.

HCP (NYSE:HCP) last released its quarterly earnings results on Tuesday, August 1st. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.47 by $0.01. HCP had a return on equity of 9.96% and a net margin of 32.16%. The firm had revenue of $458.90 million for the quarter, compared to the consensus estimate of $456.29 million. During the same quarter last year, the business posted $0.71 EPS. The company’s revenue for the quarter was down 14.8% on a year-over-year basis. On average, equities analysts forecast that HCP, Inc. will post $1.36 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, August 22nd. Shareholders of record on Monday, August 7th will be paid a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 4.97%. The ex-dividend date is Thursday, August 3rd. HCP’s dividend payout ratio is 102.07%.

WARNING: “SFE Investment Counsel Reduces Stake in HCP, Inc. (HCP)” was posted by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.watchlistnews.com/sfe-investment-counsel-reduces-stake-in-hcp-inc-hcp/1491418.html.

HCP has been the topic of several recent analyst reports. Jefferies Group LLC reissued a “hold” rating and set a $33.00 price target on shares of HCP in a research report on Tuesday, July 25th. Zacks Investment Research lowered HCP from a “hold” rating to a “sell” rating in a research report on Tuesday, July 18th. Mitsubishi UFJ Financial Group initiated coverage on HCP in a research report on Friday, April 21st. They set a “hold” rating and a $32.00 price target on the stock. Royal Bank Of Canada reissued a “hold” rating and set a $31.00 price target on shares of HCP in a research report on Wednesday, July 5th. Finally, Raymond James Financial, Inc. raised HCP from an “underperform” rating to an “outperform” rating and set a $35.00 price target on the stock in a research report on Wednesday, June 14th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have issued a buy rating to the stock. HCP has an average rating of “Hold” and an average target price of $33.42.

In other HCP news, insider Thomas Klaritch sold 2,651 shares of HCP stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total value of $83,586.03. Following the sale, the insider now owns 176,830 shares of the company’s stock, valued at approximately $5,575,449.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.22% of the company’s stock.

About HCP

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.